Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$0.98 - $1.44 $48,706 - $71,568
49,700 Added 36.54%
185,700 $206,000
Q1 2024

May 07, 2024

BUY
$1.14 - $1.53 $26,789 - $35,955
23,500 Added 20.89%
136,000 $179,000
Q4 2023

Feb 14, 2024

BUY
$0.97 - $1.6 $12,610 - $20,800
13,000 Added 13.07%
112,500 $168,000
Q3 2023

Nov 14, 2023

BUY
$1.35 - $2.87 $19,440 - $41,328
14,400 Added 16.92%
99,500 $146,000
Q2 2023

Aug 11, 2023

SELL
$1.33 - $2.51 $98,287 - $185,488
-73,900 Reduced 46.48%
85,100 $213,000
Q1 2023

May 16, 2023

SELL
$1.35 - $2.87 $21,735 - $46,207
-16,100 Reduced 9.19%
159,000 $236,000
Q4 2022

Feb 14, 2023

BUY
$1.13 - $10.8 $185,093 - $1.77 Million
163,800 Added 1449.56%
175,100 $245,000
Q3 2022

Nov 14, 2022

SELL
$3.0 - $5.49 $26,400 - $48,312
-8,800 Reduced 43.78%
11,300 $36,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $36.1M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.